Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Tripterygium wilfordii Hook F

Oral T2(Tripterygium wilfordii Hook F) 20mg thrice daily for 24 weeks.

DRUG

Methotrexate

Oral methotrexate 7.5-12.5mg per week for 24 weeks. The starting dose was 7.5mg per week, then increased to 12.5mg(max 0.3mg/Kg) per week in 4 weeks. Folic acid at the dose of 10mg per week were applied to all patients.

Trial Locations (1)

100032

Deptment of Rheumatology, Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT01613079 - Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter